BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29110756)

  • 1. APOL1 Nephropathy: A Population Genetics and Evolutionary Medicine Detective Story.
    Kruzel-Davila E; Wasser WG; Skorecki K
    Semin Nephrol; 2017 Nov; 37(6):490-507. PubMed ID: 29110756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. APOL1 Nephropathy: From Genetics to Clinical Applications.
    Friedman DJ; Pollak MR
    Clin J Am Soc Nephrol; 2021 Feb; 16(2):294-303. PubMed ID: 32616495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD.
    Freedman BI; Limou S; Ma L; Kopp JB
    Am J Kidney Dis; 2018 Nov; 72(5 Suppl 1):S8-S16. PubMed ID: 30343724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. APOL1 kidney risk alleles: population genetics and disease associations.
    Limou S; Nelson GW; Kopp JB; Winkler CA
    Adv Chronic Kidney Dis; 2014 Sep; 21(5):426-33. PubMed ID: 25168832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population genetics of chronic kidney disease: the evolving story of APOL1.
    Wasser WG; Tzur S; Wolday D; Adu D; Baumstein D; Rosset S; Skorecki K
    J Nephrol; 2012; 25(5):603-18. PubMed ID: 22878977
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Impact of APOL1 on Chronic Kidney Disease and Hypertension.
    Robinson TW; Freedman BI
    Adv Chronic Kidney Dis; 2019 Mar; 26(2):131-136. PubMed ID: 31023447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene.
    Tzur S; Rosset S; Shemer R; Yudkovsky G; Selig S; Tarekegn A; Bekele E; Bradman N; Wasser WG; Behar DM; Skorecki K
    Hum Genet; 2010 Sep; 128(3):345-50. PubMed ID: 20635188
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Friedman DJ; Pollak MR
    Annu Rev Physiol; 2020 Feb; 82():323-342. PubMed ID: 31710572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low prevalence of apolipoprotein L1 gene variants in Black South Africans with hypertension-attributed chronic kidney disease
.
    Nqebelele NU; Dickens C; Dix-Peek T; Duarte R; Naicker S
    Clin Nephrol; 2019 Jan; 91(1):40-47. PubMed ID: 30369398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying Darwinian selection acting on different human APOL1 variants among diverse African populations.
    Ko WY; Rajan P; Gomez F; Scheinfeldt L; An P; Winkler CA; Froment A; Nyambo TB; Omar SA; Wambebe C; Ranciaro A; Hirbo JB; Tishkoff SA
    Am J Hum Genet; 2013 Jul; 93(1):54-66. PubMed ID: 23768513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cell Biology of APOL1.
    O'Toole JF; Bruggeman LA; Madhavan S; Sedor JR
    Semin Nephrol; 2017 Nov; 37(6):538-545. PubMed ID: 29110761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene of the month:
    Raghubeer S; Pillay TS; Matsha TE
    J Clin Pathol; 2020 Aug; 73(8):441-443. PubMed ID: 32404472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APOL1 nephropathy: from gene to mechanisms of kidney injury.
    Kruzel-Davila E; Wasser WG; Aviram S; Skorecki K
    Nephrol Dial Transplant; 2016 Mar; 31(3):349-58. PubMed ID: 25561578
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Chaudhary NS; Moore JX; Zakai NA; Judd SE; Naik RP; Limou S; Cushman M; Lange LA; Wang HE; Winkler CA; Irvin MR; Kopp JB; Gutiérrez OM
    Clin J Am Soc Nephrol; 2019 Dec; 14(12):1733-1740. PubMed ID: 31704668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Host factors predisposing to kidney disease in people with HIV.
    Hung RKY; Winkler CA; Post FA
    Curr Opin HIV AIDS; 2023 Mar; 18(2):87-92. PubMed ID: 36722197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Brief History of APOL1: A Gene Evolving.
    Friedman DJ
    Semin Nephrol; 2017 Nov; 37(6):508-513. PubMed ID: 29110757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOL1 risk variants and kidney disease: what we know so far.
    Siemens TA; Riella MC; Moraes TP; Riella CV
    J Bras Nefrol; 2018; 40(4):388-402. PubMed ID: 30052698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APOL1 risk genotype in European steroid-resistant nephrotic syndrome and/or focal segmental glomerulosclerosis patients of different African ancestries.
    Gribouval O; Boyer O; Knebelmann B; Karras A; Dantal J; Fourrage C; Alibeu O; Hogan J; Dossier C; Tête MJ; Antignac C; Servais A
    Nephrol Dial Transplant; 2019 Nov; 34(11):1885-1893. PubMed ID: 29992269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans.
    Matsha TE; Kengne AP; Masconi KL; Yako YY; Erasmus RT
    BMC Genet; 2015 Jun; 16():69. PubMed ID: 26112018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.
    Hawkins GA; Friedman DJ; Lu L; McWilliams DR; Chou JW; Sajuthi S; Divers J; Parekh RS; Li M; Genovese G; Pollack MR; Hicks PJ; Bowden DW; Ma L; Freedman BI; Langefeld CD
    Am J Nephrol; 2015; 42(2):99-106. PubMed ID: 26343748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.